UNA Stock Analysis: Unilever | AS
Household & Personal Products | AS, Netherlands | Market Cap: 118.232m EUR | 12M Return: 7.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 54.4M
Warnings
No concerns identified
Tailwinds
Seasonality 5.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Unilever PLC is a global fast-moving consumer goods (FMCG) company headquartered in London, with operations spanning Asia Pacific, Africa, the Americas, and Europe. Founded in 1860, the company operates through four core segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods, covering everyday household and personal use categories.
The Business model relies on a portfolio of well-established consumer brands, with a strong emphasis on personal care and household products. Personal care and home care are typically higher-margin, recurring-purchase categories, while foods-such as soups, seasonings, and condiments-anchor the portfolio in stable, everyday consumption. Brand loyalty and global distribution scale are central to the companys competitive position in the consumer staples sector.
Unilever markets its products under numerous globally recognized names, including Dove, Knorr, Hellmanns, AXE, Rexona, Sunsilk, TRESemmé, Vaseline, and OMO, among others. The extensive brand portfolio spans mass-market and premium offerings (e.g., Dermalogica, Nutrafol, Paulas Choice), allowing the company to address a broad range of price points and consumer segments worldwide.
- Emerging market demand drives volume growth in Personal Care
- Ice cream spin-off sharpens focus on higher-margin Beauty
- Margin recovery under Schumacher action plan gains traction
| Net Income: 6.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.25 > 1.0 |
| NWC/Revenue: -9.12% < 20% (prev -9.94%; Δ 0.82% < -1%) |
| CFO/TA 0.11 > 3% & CFO 7.95b > Net Income 6.09b |
| Net Debt (25.9b) to EBITDA (11.1b): 2.33 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.20b) vs 12m ago -13.16% < -2% |
| Gross Margin: 47.87% > 18% (prev 45.05%; Δ 2.82% > 0.5%) |
| Asset Turnover: 67.16% > 50% (prev 76.19%; Δ -9.03% > 0%) |
| Interest Coverage Ratio: 9.66 > 6 (EBIT TTM 9.78b / Interest Expense TTM 1.01b) |
| A: -0.07 (Total Current Assets 17.1b - Total Current Liabilities 21.7b) / Total Assets 70.6b |
| B: 0.63 (Retained Earnings 44.3b / Total Assets 70.6b) |
| C: 0.13 (EBIT TTM 9.78b / Avg Total Assets 75.2b) |
| D: 0.29 (Book Value of Equity 15.6b / Total Liabilities 53.0b) |
| Altman-Z'' = 2.80 = A |
| DSRI: 1.81 (Receivables 7.69b/5.12b, Revenue 50.5b/60.8b) |
| GMI: 0.94 (GM 45.05% / 47.87%) |
| AQI: 1.03 (AQ_t 0.63 / AQ_t-1 0.61) |
| SGI: 0.83 (Revenue 50.5b / 60.8b) |
| TATA: -0.03 (NI 6.09b - CFO 7.95b) / TA 70.6b) |
| Beneish M = -2.52 (Cap -4..+1) = A |
As of July 23, 2026, the stock is trading at EUR 54.09 with a total of 835,303 shares traded. Over the past week, the price has changed by +0.60%, over one month by +6.08%, over three months by +12.34% and over the past year by +7.37%.
Current recommended Stop Loss: 51.80 (which is 4.2% or 2.3 ATR below the current price).
Unilever has no consensus analysts rating.
P/E Trailing = 21.2008
P/E Forward = 17.4825
P/S = 2.3411
P/B = 7.5646
P/EG = 11.6581
Revenue TTM = 50.5b EUR
EBIT TTM = 9.78b EUR
EBITDA TTM = 11.1b EUR
Long Term Debt = 24.1b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.59b EUR (from shortTermDebt, last quarter)
Debt = 31.0b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 25.9b EUR (calculated: Debt 31.0b - CCE 5.07b)
Enterprise Value = 144b EUR (118b + Debt 31.0b - CCE 5.07b)
Interest Coverage Ratio = 9.66 (Ebit TTM 9.78b / Interest Expense TTM 1.01b)
EV/FCF = 20.40x (Enterprise Value 144b / FCF TTM 7.07b)
FCF Yield = 4.90% (FCF TTM 7.07b / Enterprise Value 144b)
FCF Margin = 14.00% (FCF TTM 7.07b / Revenue TTM 50.5b)
Net Margin = 12.07% (Net Income TTM 6.09b / Revenue TTM 50.5b)
Gross Margin = 47.87% ((Revenue TTM 50.5b - Cost of Revenue TTM 26.3b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 2.04 (Enterprise Value 144b / Total Assets 70.6b)
Interest Expense / Debt = 3.27% (Interest Expense 1.01b / Debt 31.0b)
Taxrate = 28.04% (2.44b / 8.69b)
NOPAT = 7.04b (EBIT 9.78b * (1 - 28.04%))
Current Ratio = 0.79 (Total Current Assets 17.1b / Total Current Liabilities 21.7b)
Debt / Equity = 1.99 (Debt 31.0b / totalStockholderEquity, last quarter 15.6b)
Debt / EBITDA = 2.33 (Net Debt 25.9b / EBITDA 11.1b)
Debt / FCF = 3.67 (Net Debt 25.9b / FCF TTM 7.07b)
Total Stockholder Equity = 18.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.11% (Net Income 6.09b / Total Assets 70.6b)
RoE = 33.09% (Net Income TTM 6.09b / Total Stockholder Equity 18.4b)
RoCE = 23.02% (EBIT 9.78b / Capital Employed (Equity 18.4b + L.T.Debt 24.1b))
RoIC = 14.38% (NOPAT 7.04b / Invested Capital 48.9b)
WACC = 4.66% (E(118b)/V(149b) * Re(5.27%) + D(31.0b)/V(149b) * Rd(3.27%) * (1-Tc(0.28)))
Discount Rate = 5.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -69.11 | Cagr: -6.50%
[DCF] Terminal Value 74.09% ; FCFF base≈7.35b ; Y1≈6.81b ; Y5≈6.14b
[DCF] Fair Price = 33.15 (EV 97.3b - Net Debt 25.9b = Equity 71.4b / Shares 2.15b; r=8.35% [WACC [floored]]; 5y FCF grow -9.20% → 2.50% )
EPS Correlation: -45.16 | EPS CAGR: -10.09% | SUE: 0.0 | # QB: 0
Revenue Correlation: 53.34 | Revenue CAGR: 9.05% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=3.22 | Chg30d=+0.03% | Revisions=-17% | GrowthEPS=+4.5% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=3.39 | Chg30d=+0.01% | Revisions=+0% | GrowthEPS=+5.3% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -12% (up=2, down=3)